Judge Nixes Bayer Patent Suit Over Centocor's Simponi

Law360, New York (January 31, 2011, 4:46 PM EST) -- A federal judge has closed the book on Bayer HealthCare LLC's patent infringement suit over Johnson & Johnson unit Centocor Ortho Biotech Inc.'s arthritis drug Simponi.

Judge F. Dennis Saylor IV entered a final judgment of no infringement for Centocor in the U.S. District Court for the District of Massachusetts on Friday.

On Jan. 25, Centocor and Bayer entered a stipulation for the final judgment, agreeing that the patent has not been infringed due to Judge Saylor's claim construction ruling, which was handed down in December....
To view the full article, register now.